SlidesetHIVInternational Workshop on Aging & HIV 2016(Abstract) Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults | Dr. K. ErlandsonView Slideset
SlidesetHIVInternational Workshop on Aging & HIV 2016(Abstract) HIV-Infection Attenuates the Age Associated Slowing of Resting Metabolic Rate | Jennifer Schrack, PhDView Slideset
SlidesetHIVInternational Workshop on Aging & HIV 2016HIV treaters view | Cynthia Gibert, MD, MScView Slideset
ESEugenia SieglerMDSlidesetHIVInternational Workshop on Aging & HIV 2016Non-HIV care provider | Eugenia Siegler, MDView Slideset
SlidesetHIVInternational Workshop on Aging & HIV 2016Focus on psychosocial needs | Molly Perkins, PhDView Slideset
SlidesetHIVInternational Workshop on Aging & HIV 2016The effect of age on immune system reconstitution among HIV infected patients on antiretroviral therapy in resource limited settings | Dr. K. StaffordView Slideset
SlidesetHIVInternational Workshop on Aging & HIV 2016Circulating LOXL2 Levels Reflect Severity of Intestinal Fibrosis and CD4+ T Lymphocyte Depletion in Treated HIV Infection | Dr. J. LakeView Slideset
SlidesetHIVInternational Workshop on Aging & HIV 2016HIV-1 Infection Accelerates Age According to the Epigenetic Clock | Steve Horvath, PhDView Slideset
SlidesetHIVInternational Workshop on Aging & HIV 2016Future challenges for clinical care in the ageing HIV-population: a “geriatric-HIV” modelling study | Dr. G. GuaraldView Slideset
CFCharles FlexnerMDVideoHIVSalvador HIV Clinical Forum 2021Long-Acting Drugs for Treatment and Prevention - Charles Flexner, MD (v)View Video
EPNEstevão Portela NunesMD, PhDVideoHIVSalvador HIV Clinical Forum 20212 vs 3 Drugs: When and for Whom? - Estevão Portela Nunes, MD, PhD (v)View Video
